Journal Mobile Options
Table of Contents
Vol. 37, No. 5, 2000
Issue release date: September–October 2000
Section title: Research Paper
J Vasc Res 2000;37:372–380
(DOI:10.1159/000025753)

Gene Transfer to Intact Mesenteric Arteries by Electroporation

Martin J.B. · Young J.L. · Benoit J.N. · Dean D.A.
Departments of aPhysiology and bMicrobiology and Immunology, University of South Alabama College of Medicine, Mobile, Ala., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restriction apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Research Paper

Published online: 10/2/2000

Number of Print Pages: 9
Number of Figures: 5
Number of Tables: 0

ISSN: 1018-1172 (Print)
eISSN: 1423-0135 (Online)

For additional information: http://www.karger.com/JVR

Abstract

The purpose of the present study was to develop a rapid, reproducible method of nonviral gene transfer to the intact vasculature. Male Sprague-Dawley rats were anesthetized, a midline abdominal incision was made and segmental branches of the superior mesenteric artery were dissected free of surrounding mesentery. A specially designed electroporation probe was placed around the neurovascular bundle and the electroporation chamber filled with a solution containing the firefly luciferase expressing plasmid (pCMV-Lux-DTS) or the green fluorescent protein expressing plasmid (pEGFP-N1). Vessels were electroporated with eight 10-ms pulses of 200 V/cm. Sixty seconds after electroporation, the DNA solution was removed, the intestine returned to the abdomen and the abdominal wall closed with suture and metal wound clips. Six hours to 5 days later, rats were sacrificed and electroporated vessels were recovered. Luciferase activity of the blood vessels was monitored. Gene expression was detected as early as 6 h postelectroporation, peaked at 1–3 days with levels up to 1 ng of reporter gene product per vessel segment and returned towards baseline by day 5. Histological analysis of blood vessel segments revealed green fluorescent protein-positive cells throughout the thickness of the vessel wall (endothelial cells to adventitia). Responses of electroporated vessels to vasoconstricting stimuli were indistinguishable from those of control vessels at either 2 or 40 days posttreatment. The results of this study provide evidence that electroporation is an effective means for introducing naked DNA into the blood vessel wall and form the basis for future studies on targeted gene therapy to the intact vasculature.


Article / Publication Details

First-Page Preview
Abstract of Research Paper

Published online: 10/2/2000

Number of Print Pages: 9
Number of Figures: 5
Number of Tables: 0

ISSN: 1018-1172 (Print)
eISSN: 1423-0135 (Online)

For additional information: http://www.karger.com/JVR


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Parker SE, Vahlsing HL, Serfilippi LM, Franklin CL, Doh SG, Gromkowski SH, Lew D, Manthorpe M, Norman J: Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates. Hum Gene Ther 1995;6:575–590.
  2. Mir LM, Banoun H, Paoletti C: Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: Direct access to the cytosol. Exp Cell Res 1988;175:15–25.

    External Resources

  3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York, Wiley, 1994.
  4. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud J-M, Delaere P, Branellec D, Schwartz B, Scherman D: High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999;96:4262–4267.
  5. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, Mathiesen I, Cortese R, Ciliberto G, Laufer R, La Monica N, Fattori E: Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999;96:6417–6422.
  6. Mathiesen I: Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999;6:508–514.

    External Resources

  7. Aihara H, Miyazaki J: Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998;16:867–870.
  8. Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, Nicolau C: In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996;389:225–228.
  9. Suzuki T, Shin BC, Fujikura K, Matsuzaki T, Takata K: Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett 1998;425:436–440.
  10. Oshima Y, Sakamoto T, Yamanaka I, Nishi T, Ishibashi T, Inomata H: Targeted gene transfer to corneal endothelium in vivo by electric pulse. Gene Ther 1998;5:1347–1354.
  11. Nishi T, Yoshizato K, Yamashiro S, Takeshima H, Sato K, Hamada K, Kitamura I, Yoshimura T, Saya H, Kuratsu J, Ushio Y: High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res 1996;56:1050–1055.
  12. Harrison RL, Byrne BJ, Tung L: Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett 1998;435:1–5.
  13. Muramatsu T, Nakamura A, Park H: In vivo electroporation: A powerful and convenient means of nonviral gene transfer to tissues of living animals. Int J Mol Med 1998;1:55–62.
  14. Dev NB, Preminger TJ, Hofmann GA, Dev SB: Sustained local delivery of heparin to the rabbit arterial wall with an electroporation catheter. Cathet Cardiovasc Diagn 1998;45:337–345.
  15. Liu MW, Roubin GS, King SB 3rd: Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374–1387.
  16. Vacik J, Dean BS, Zimmer WE, Dean DA: Cell-specific nuclear import of plasmid DNA. Gene Ther 1999;6:1006–1014.

    External Resources

  17. Manthorpe M, Hartikka J, Vahlsing HL, Sawdey M: Quantification of plasmid DNA expression in vivo; in Ferre F (ed): Gene Quantification. Burhauser, Cambridge, 1996.
  18. Mesh CL, Joh T, Korthuis RJ, Granger DN, Benoit JN: Intestinal vascular sensitivity to vasopressin in portal hypertensive rats. Gastroenterology 1991;100:916–921.
  19. Benoit JN, Womack WA, Korthuis RJ, Wilborn WH, Granger DN: Chronic portal hypertension: Effects on gastrointestinal blood flow distribution. Am J Physiol 1986;250:G535–G539.

    External Resources

  20. Schachtner SK, Rome JJ, Hoyt RF, Newman KD, Virmani R, Dichek DA: In vivo adenovirus-mediated gene transfer via the pulmonary artery of rats. Circ Res 1995;76:701–709.
  21. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA: In vivo adenoviral vector mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 1993;73:797–807.
  22. Rolling F, Nong Z, Pisvin S, Collen D: Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther 1997;4:757–761.
  23. Yew NS, Wysokenski DM, Wang KX, Ziegler RJ, Marshall J, McNeilly D, Cherry M, Osburn W, Cheng SH: Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum Gene Ther 1997;8:575–584.
  24. Daheshia M, Kuklin N, Kanangat S, Manickan E, Rouse BT: Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J Immunol 1997;159:1945–1952.
  25. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A: Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992;1:363–369.